Stockscreener 앱 받기
0.2917
12.84%
0.0332
전일 마감가:
$0.2585
열려 있는:
$0.2558
하루 거래량:
12.08M
Relative Volume:
1.39
시가총액:
$9.76M
수익:
-
순이익/손실:
$-22.71M
주가수익비율:
-0.0249
EPS:
-11.71
순현금흐름:
$-18.24M
1주 성능:
+27.10%
1개월 성능:
+24.39%
6개월 성능:
-15.45%
1년 성능:
-32.16%
1일 변동 폭
$0.2482
$0.3189
1주일 범위
$0.20
$0.4045
52주 변동 폭
$0.14
$3.97
Genprex Inc Stock (GNPX) Company Profile
명칭
Genprex Inc
전화
512-537-7997
주소
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
GNPX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.2917 | 8.37M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-01-26 | 개시 | National Securities | Buy |
| 2019-04-29 | 개시 | Noble Capital Markets | Outperform |
Genprex Inc 주식(GNPX)의 최신 뉴스
Will Genprex Inc. continue its uptrendTrade Signal Summary & Real-Time Stock Price Movement Reports - Newser
Identifying reversal signals in Genprex Inc.Trade Analysis Summary & Stepwise Trade Signal Guides - Newser
Genprex (GNPX) Files to Sell 25 Million Common Shares - GuruFocus
Quantitative breakdown of Genprex Inc. recent move2025 Investor Takeaways & Weekly Consistent Profit Watchlists - Newser
What machine learning models say about Genprex Inc.Quarterly Profit Review & Target Return Focused Stock Picks - Newser
Institutional scanner results for Genprex Inc.July 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Short interest data insights for Genprex Inc.Trade Exit Summary & Weekly Breakout Stock Alerts - Newser
Ranking Genprex Inc. among high performing stocks via toolsPortfolio Return Summary & Short-Term Trading Alerts - Newser
Using R and stats models for Genprex Inc. forecastingWeekly Market Report & Daily Technical Forecast Reports - Newser
How to escape a deep drawdown in Genprex Inc.Earnings Trend Report & Daily Technical Forecast Reports - Newser
Genprex Inc.’s volatility index tracking explainedInsider Selling & Verified Entry Point Signals - Newser
What earnings revisions data tells us about Genprex Inc.Options Play & Real-Time Volume Trigger Notifications - Newser
Using AI based signals to follow Genprex Inc.Weekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Genprex Inc. stock daily chart insightsJuly 2025 Update & Breakout Confirmation Trade Signals - Newser
Custom watchlist performance reports with Genprex Inc.Global Markets & Stepwise Trade Execution Plans - Newser
Using Ichimoku Cloud for Genprex Inc. technicals2025 Historical Comparison & AI Enhanced Trading Signals - Newser
How to use Fibonacci retracement on Genprex Inc.2025 Institutional Moves & Weekly Watchlist for Hot Stocks - Newser
Will earnings trigger a reversal in Genprex Inc.Market Activity Summary & Consistent Income Trade Recommendations - Newser
Statistical indicators supporting Genprex Inc.’s strengthDay Trade & Weekly Return Optimization Plans - Newser
Genprex Inc. stock volume spike explainedJuly 2025 Gainers & Weekly High Return Forecasts - Newser
Genprex Inc. stock chart pattern explained2025 Volatility Report & AI Powered Buy/Sell Recommendations - Newser
Has Genprex Inc. formed a bullish divergenceTrade Signal Summary & Smart Swing Trading Alerts - Newser
Genprex Is Betting On Gene Therapy, But Risks Remain High - Finimize
will genprex inc. continue its uptrendRate Cut & Real-Time Volume Trigger Notifications - Newser
Ryan Confer, President and Chief Executive Officer of Genprex, Inc., to Present at Investor Summit Virtual on September 16, 2025 - FinancialContent
Genprex Inc. stock trend forecast2025 Biggest Moves & Low Risk High Win Rate Picks - Newser
Chartists Watching For Breakout in Genprex Inc.Earnings Risk Summary & Community Consensus Picks - Newser
Is Genprex Inc. stock undervalued right nowJuly 2025 Fed Impact & Stock Market Timing Techniques - Lancaster City Council
Will Genprex Inc. outperform tech stocks2025 EndofYear Setup & Expert Approved Trade Ideas - Lancaster City Council
Genprex Inc (GNPX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):